Latest Viatris News | Viatris News | Viatris Funding | Viatris Fund - vccircle
Advertisement

Viatris

Premium
Deals Digest: Momentum falls marginally this week; M&A volume also lacklustre

General

14 June, 2024

Deals Digest: Momentum falls marginally this week; M&A volume also lacklustre

Private Equity (PE) and venture capital (VC) dealmaking activity this week saw a slight dip in terms of value, while ......

Kotak fund to part-finance Matrix Pharma's purchase of Viatris API business

Healthcare

11 June, 2024

Kotak fund to part-finance Matrix Pharma's purchase of Viatris API business

Kotak Alternate Asset Managers Ltd, the alternative investment arm of Kotak Group, said Monday it will part-finance the acquisition of Viatris Inc's ......

Premium
Grapevine: CX Partners starts Veeda Clinical sale process; Ola CEO departs amid job cuts

General

30 April, 2024

Grapevine: CX Partners starts Veeda Clinical sale process; Ola CEO departs amid job cuts

CX Partners, a mid-market private equity firm, has started the process to divest its majority stake in Veeda Clinical Research, an ......

Premium
Grapevine: KKR mulls JB Pharma sale; Bharti eyes Del Monte JV exit

General

29 February, 2024

Grapevine: KKR mulls JB Pharma sale; Bharti eyes Del Monte JV exit

Private equity firm KKR & Co. is exploring options for a potential sale of its 53.8% controlling stake in Mumbai-based ......

Matrix Labs founder Nimmagadda Prasad's firm buys Viatris' India API business

Healthcare

03 October, 2023

Matrix Labs founder Nimmagadda Prasad's firm buys Viatris' India API business

Viatris Inc., the result of the merger between Mylan NV and Pfizer Inc.’s Upjohn unit in 2020, has sold two ......

Biocon Biologics appoints new MD, CEO

Healthcare

05 December, 2022

Biocon Biologics appoints new MD, CEO

Biocon Biologics on Monday said it has appointed Shreehas Tambe as managing director and chief executive officer of the company. ......

Biocon concludes Viatris' $3 bn acquisition

Healthcare

30 November, 2022

Biocon concludes Viatris' $3 bn acquisition

Biosimilars manufacturing arm of Biocon Ltd, Biocon Biologics, on Tuesday announced completion of acquisition of Viatris' global biosimilars business for ......

Premium
Analysis: M&A deal value in healthcare and pharma hits record high in Jan-June

Healthcare

11 July, 2022

Analysis: M&A deal value in healthcare and pharma hits record high in Jan-June

Merger and acquisitions (M&As) deal value in the healthcare and pharmaceutical space hit a record high in Jan-June, crossing the ......

India's Biocon in talks with Mylan to merge biosimilar businesses - Moneycontrol

Healthcare

09 December, 2021

India's Biocon in talks with Mylan to merge biosimilar businesses - Moneycontrol

Indian drugmaker Biocon Ltd is in talks with generic drugmaker Mylan for a merger of their biosimilar businesses, financial news ......